LDV Blog

Our 12th Annual LDV Vision Summit brought together deep tech entrepreneurs, technologists, academics, researchers and investors for engaging discussions on innovations in cutting-edge visual tech and AI. We continue to be excited by the accelerating convergence of visual tech and AI across both the digital and physical worlds.

We were thrilled to welcome speakers from Insight Partners, Mayo Clinic, Harvard Medical School, Bek Ventures, 01 Advisors, University of Oxford, The Pioneer Centre for Artificial Intelligence, and LocalGlobe among others.

A special thank you goes to our speakers and attendees!

Since founding in 2012, LDV Capital is a thesis-driven early-stage venture fund investing in people building businesses powered by visual technology and artificial intelligence. Our thesis = a majority of the data our brains analyze is visual. Therefore, the majority of the data artificial intelligence will analyze will also be visual across the light and electromagnetic spectrum.

People used to say that our thesis was cute, niche and science fiction. Now it is validated.

We invest horizontally across all sectors such as: agriculture, healthcare, nanotechnology, logistics, manufacturing, entertainment, mobility, construction, optics, sensors, life sciences and biotech, robotics, materials science, video, mapping, security and much more.

LDV Capital IV: We are investing out of our 4th fund which was announced in 2024.

LDV Capital I & II are returned. We continue to have significant upside potential across each of our funds thanks to our brilliant entrepreneurs, experts, team and LP partners.

We’re excited to welcome Ross Cooke to our LDV Capital team. We were impressed by his communication style, problem-solving skills and expertise in nanoscience, physics, chemistry of advanced materials and materials science. Ross is particularly interested in how visual technologies and AI can transform long-established industries where innovation can have an outsized impact, such as healthcare, energy and mining.

Our 11th Annual LDV Vision Summit was our most attended event to date, bringing together deep tech entrepreneurs, technologists, academics, researchers and investors for engaging discussions on cutting-edge visual tech and AI innovations. We were thrilled to welcome speakers from Sequoia Capital, NVIDIA, IBM, Kleiner Perkins, Phare Bio, IVP, Mitra Chem, BAM Corner Point, Duke University, Fortune, Argonne National Laboratory, Princeton University, The Pioneer Centre for Artificial Intelligence and Fieldstone Bio.

We are thrilled to share that we have returned our LDV Capital I & II funds. We continue to have significant upside potential across each of our funds thanks to our brilliant entrepreneurs, experts, team and LP partners.

We continue investing out of our LDV Capital IV fund.

Our LPs say we are highly differentiated, disciplined, have high-quality sourcing and successfully create value by investing in category leaders at the earliest stages.

In September 2021, Ash Cleary began his venture capital journey by joining Evan Nisselson and our LDV Capital team as an Analyst, investing out of Fund III as part of a two-year program. After successfully completing the program, Ash was promoted to Associate and now invests out of LDV Capital's fourth fund.

Check out his insights and reflections on the past three years—working with the team and collaborating with brilliant deep tech entrepreneurs worldwide, building businesses powered by visual technology and artificial intelligence.

Meet Dr. Molly Gibson – Co-Founder and Chief Strategy & Innovation Officer at Generate:Biomedicines, Origination Partner at Flagship Pioneering. LDV Capital's Founder & General Partner Evan Nisselson discussed with Molly how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials and more.

We are pleased to announce that we have raised our fourth LDV Capital fund with $31M. We will continue investing in the same unique thesis that has not changed since founding LDV Capital in 2012. The majority of data our brains analyze is visual so the majority of data that AI will analyze will be visual as well. Visual data and visual technologies are critical for the success of artificial intelligence horizontally across all sectors.

As the biotech industry relies heavily on data filtering, analysis and sharing, visual technologies will become critical for the detection and imaging of biological systems, paving the way for the future of life sciences tools enabling next-generation therapeutics, biomanufacturing & longevity.

We at LDV Capital have been investing in AI for over 10 years to date, and have made 7 investments in teams building businesses leveraging Generative AI since 2018. We believe that this technology has significant commercial value as a utility that will empower SaaS businesses to disrupt legacy enterprises. Check out this article to learn more and see some examples of exponentially growing commercial applications in content creation, biotech and more.

The next guest in our Women Leading Visual Tech series is Dr. Sujatha Ramanujan, a serial entrepreneur and seasoned executive with 25 years of experience in medical devices and consumer electronics. She currently serves as the Managing Director of Luminate – the world’s largest accelerator for startups with optics, photonics, and imaging enabled applications. LDV Capital’s Abigail Hunter-Syed spoke with Sujatha about managing a crisis, fear of boredom, and a mission to revitalize the Rochester area.